Joachim M Baehring
Overview
Explore the profile of Joachim M Baehring including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hai L, Friedel D, Hinz F, Hoffmann D, Doubrovinskaia S, Rohdjess H, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39575767
Background: Epstein-Barr virus (EBV)+ and EBV- primary CNS lymphomas (PCNSL) carry distinct mutational landscapes, but their transcriptional and epigenetic profiles have not been integrated and compared. This precludes further insights...
2.
3.
Doubrovinskaia S, Egert A, Karschnia P, Scheffler G, Traub B, Galluzzo D, et al.
J Neurooncol
. 2024 Aug;
170(2):309-317.
PMID: 39115616
Background: Neurolymphomatosis refers to infiltration of the peripheral nervous system (PNS) by non-Hodgkin lymphoma (NHL). Diagnostic intervals in neurolymphomatosis and factors delaying diagnosis have not been evaluated. We therefore aimed...
4.
Kaulen L, Hielscher T, Doubrovinskaia S, Hoffmann D, Kessler T, Traub B, et al.
Neurology
. 2024 Aug;
103(4):e209698.
PMID: 39102613
Background And Objectives: Neurolymphomatosis (NL) refers to lymphomatous infiltration of the peripheral nervous system (PNS). NL diagnosis and treatment are challenging given the broad differential diagnosis of peripheral neuropathy, the...
5.
Perez M, Barrionuevo V, Arias C, Baehring J
Cureus
. 2024 Jul;
16(6):e61540.
PMID: 38957232
The standard chemotherapy for treating oligodendrogliomas consists of a combination of procarbazine, lomustine, and vincristine (PCV). The combination of hypomethylating agents like azacitidine and BCL2 inhibitors like venetoclax has not...
6.
Kaulen L, Denisova E, Hinz F, Hai L, Friedel D, Henegariu O, et al.
Acta Neuropathol
. 2023 Jul;
146(3):499-514.
PMID: 37495858
Immunodeficiency-associated primary CNS lymphoma (PCNSL) represents a distinct clinicopathological entity, which is typically Epstein-Barr virus-positive (EBV) and carries an inferior prognosis. Genetic alterations that characterize EBV-related CNS lymphomagenesis remain unclear...
7.
Zubair A, Roy B, Baehring J, Nowak R
Cureus
. 2022 Nov;
14(10):e30638.
PMID: 36439604
Use of immune checkpoint inhibitors (ICI) is increasing in patients with oncologic disease. Three classes of checkpoint inhibitors exist: anti-PD1 (nivolumab, pembrolizumab), anti-CTLA4 (ipilimumab), and anti-PDL1 (atezolizumab, avelumab, durvalumab). ICI...
8.
Kaulen L, Baehring J
Curr Treat Options Oncol
. 2022 Oct;
23(11):1548-1565.
PMID: 36205806
Primary CNS lymphoma (PCNSL) constitutes a rare extranodal variant of non-Hodgkin lymphoma (NHL) with an annual incidence of 0.45/100,000. Given the paucity of large prospective clinical trials, there is no...
9.
Sanborn R, Pishvaian M, Callahan M, Weise A, Sikic B, Rahma O, et al.
J Immunother Cancer
. 2022 Aug;
10(8).
PMID: 35940825
Background: Phase 1/2 dose-escalation and expansion study evaluating varlilumab, a fully human agonist anti-CD27 mAb, with nivolumab in anti-PD-1/L1 naïve, refractory solid tumors. Methods: Phase 1 evaluated the safety of...
10.
Bower A, Fisayo A, Baehring J, Roy B
Neurology
. 2022 Mar;
98(18):767-772.
PMID: 35264421
A 73-year-old woman presented with transient episodes of dysarthria and horizontal diplopia. She had stereotactic radiosurgery 18 years prior for a retroclival meningioma. Neurologic examination was notable for right-sided tongue...